Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$153,793,325
+$41,057,117 QoQ
Shares Held
128,222
+4.6% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
1.34%
of 13F equity value
Holder Rank
#306
of 4,605 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026B. Metzler seel. Sohn & Co. AG holds $558,946,966 across 9 Drug Manufacturers - General names. LLY ranks #2 (27.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
867,621 | $218,328,147 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
128,222 | $153,793,325 | |
| 3 | JNJ |
Johnson & Johnson
|
310,590 | $78,880,542 | |
| 4 | MRK |
Merck & Co., Inc.
|
443,208 | $56,952,227 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
114,360 | $14,448,242 | |
| 6 | AMGN |
Amgen Inc
|
39,041 | $14,137,526 | |
| 7 | PFE |
Pfizer Inc
|
576,524 | $13,882,696 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
101,975 | $5,875,798 |
All Filings in LLY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $153,793,325 | 128,222 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $112,736,208 | 122,570 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $129,516,146 | 120,516 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $106,662,059 | 139,793 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $85,133,250 | 109,211 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $73,866,911 | 89,437 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $58,628,768 | 75,944 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $85,850,243 | 96,903 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $97,779,228 | 107,998 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $77,771,105 | 99,968 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $66,060,574 | 113,327 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $67,103,650 | 124,930 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $57,592,150 | 122,803 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $41,147,554 | 119,817 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $44,590,408 | 121,885 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $41,826,938 | 129,355 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $42,599,282 | 131,386 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $38,214,357 | 133,444 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $35,591,774 | 128,853 | Shares | Defined | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||